Načítá se...

Selegiline reduces daytime sleepiness in patients with Parkinson's disease

OBJECTIVES: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who were given...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Behav
Hlavní autoři: Gallazzi, Marco, Mauri, Marco, Bianchi, Maria Laura, Riboldazzi, Giulio, Princiotta Cariddi, Lucia, Carimati, Federico, Rebecchi, Valentina, Versino, Maurizio
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119812/
https://ncbi.nlm.nih.gov/pubmed/33759401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1880
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!